title: Review of the processes for FDA oversight of drugs, medical devices, and combination products.
authors.affiliation: Drug Information Service, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-5008, USA. gsweet@umich.edu
authors.forename: Burgunda V
authors.initials: BV
authors.lastname: Sweet
authors.forename: Ann K
authors.initials: AK
authors.lastname: Schwemm
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Parsons
mesh_terms: D018795:Device Approval; D017277:Drug Approval; D016527:Drug Costs; D064420:Drug-Related Side Effects and Adverse Reactions; D004869:Equipment Safety; D004864:Equipment and Supplies / Q000145:classification; D017048:Health Care Costs; D049673:History, 20th Century; D007880:Legislation, Drug; D056687:Off-Label Use; D004364:Pharmaceutical Preparations / Q000145:classification; D014481:United States; D014486:United States Food and Drug Administration / Q000266:history
chemical_list: D004364:Pharmaceutical Preparations